Stability Indicating RP-HPLC Estimation of Atorvastatin Calcium and Amlodipine Besylate in Pharmaceutical Formulations
2008

Method for Measuring Atorvastatin and Amlodipine in Tablets

Sample size: 20 publication Evidence: high

Author Information

Author(s): Shah D. A., Bhatt K. K., Mehta R. S., Baldania S. L., Gandhi T. R.

Primary Institution: Indukaka Ipcowala College of Pharmacy

Hypothesis

A stability indicating RP-HPLC method can accurately estimate atorvastatin calcium and amlodipine besylate in pharmaceutical formulations.

Conclusion

The developed method is simple, accurate, and effective for estimating atorvastatin and amlodipine in combined tablet dosage forms.

Supporting Evidence

  • The method was validated for accuracy, precision, specificity, detection limit, quantitation limit, and robustness.
  • Recovery rates for atorvastatin and amlodipine were between 98.52% and 99.83%.
  • The detection limits for atorvastatin and amlodipine were 0.03 μg/ml and 0.04 μg/ml, respectively.

Takeaway

Researchers created a way to measure two medicines in tablets to make sure they work well and are safe.

Methodology

A reversed phase high performance liquid chromatographic method was developed and validated for the simultaneous determination of atorvastatin and amlodipine.

Limitations

The method may not be applicable to other formulations or drugs without further validation.

Digital Object Identifier (DOI)

10.4103/0250-474X.49117

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication